Clinical Trial Update: Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating activated white blood cells with autologous stem cell transplant for newly diagnosed multiple myeloma completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-12-19